CVS Group plc (LON:CVSG – Get Free Report) insider Deborah Kemp bought 2,440 shares of the business’s stock in a transaction on Wednesday, June 26th. The stock was bought at an average price of GBX 1,024 ($12.99) per share, with a total value of £24,985.60 ($31,695.55).
CVS Group Stock Down 0.8 %
Shares of CVS Group stock traded down GBX 8 ($0.10) during midday trading on Thursday, reaching GBX 1,010 ($12.81). 109,142 shares of the company’s stock traded hands, compared to its average volume of 276,232. The company has a market cap of £723.87 million, a price-to-earnings ratio of 2,065.31, a price-to-earnings-growth ratio of 1.77 and a beta of 0.95. The company’s 50 day simple moving average is GBX 1,039.07 and its 200 day simple moving average is GBX 1,302.88. The company has a debt-to-equity ratio of 100.75, a quick ratio of 0.90 and a current ratio of 1.15. CVS Group plc has a 52 week low of GBX 902.41 ($11.45) and a 52 week high of GBX 2,225 ($28.23).
Analyst Ratings Changes
Separately, Berenberg Bank reiterated a “buy” rating and issued a GBX 2,370 ($30.06) target price on shares of CVS Group in a research report on Tuesday, May 21st.
CVS Group Company Profile
CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.
Recommended Stories
- Five stocks we like better than CVS Group
- Investing in Construction Stocks
- BlackBerry Stock: Strong Earnings, Profitability Challenges Ahead
- Stock Market Sectors: What Are They and How Many Are There?
- Progress Software Stock Back in the Green After Beating Forecasts
- Top Stocks Investing in 5G Technology
- Goldman Sachs Raises Stock Target for Affirm: Key Insights
Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with MarketBeat.com's FREE daily email newsletter.